200 related articles for article (PubMed ID: 36350016)
21. Neurodevelopmental Outcomes at 18 Months of Corrected Age for Late Preterm Infants Born at 34 and 35 Gestational Weeks.
Nakasone R; Fujioka K; Kyono Y; Yoshida A; Kido T; Suga S; Abe S; Ashina M; Nishida K; Tanimura K; Yamada H; Nozu K; Iijima K
Int J Environ Res Public Health; 2021 Jan; 18(2):. PubMed ID: 33451096
[TBL] [Abstract][Full Text] [Related]
22. Fetal premature atrial contractions: natural course, risk factors and adverse outcome.
Bet BB; Eijsbroek FC; van Leeuwen E; Linskens IH; Knobbe I; Clur SA; Pajkrt E
Ultrasound Obstet Gynecol; 2024 May; 63(5):650-657. PubMed ID: 38030959
[TBL] [Abstract][Full Text] [Related]
23. Association of inotrope use with neurodevelopmental outcomes in infants <29 weeks gestation: a retrospective cohort study.
Doucette SM; Kelly EN; Church PT; Lee S; Shah V;
J Matern Fetal Neonatal Med; 2022 Dec; 35(25):6044-6052. PubMed ID: 33827395
[TBL] [Abstract][Full Text] [Related]
24. Comparison of transplacental treatment of fetal supraventricular tachyarrhythmias with digoxin, flecainide, and sotalol: results of a nonrandomized multicenter study.
Jaeggi ET; Carvalho JS; De Groot E; Api O; Clur SA; Rammeloo L; McCrindle BW; Ryan G; Manlhiot C; Blom NA
Circulation; 2011 Oct; 124(16):1747-54. PubMed ID: 21931080
[TBL] [Abstract][Full Text] [Related]
25. Neurodevelopmental Outcomes of Infants Born at <29 Weeks of Gestation Admitted to Canadian Neonatal Intensive Care Units Based on Location of Birth.
Amer R; Moddemann D; Seshia M; Alvaro R; Synnes A; Lee KS; Lee SK; Shah PS;
J Pediatr; 2018 May; 196():31-37.e1. PubMed ID: 29305231
[TBL] [Abstract][Full Text] [Related]
26. Effectiveness of sotalol as first-line therapy for fetal supraventricular tachyarrhythmias.
Shah A; Moon-Grady A; Bhogal N; Collins KK; Tacy T; Brook M; Hornberger LK
Am J Cardiol; 2012 Jun; 109(11):1614-8. PubMed ID: 22444730
[TBL] [Abstract][Full Text] [Related]
27. Fetal tachycardia: intrauterine and postnatal course.
Naumburg E; Riesenfeld T; Axelsson O
Fetal Diagn Ther; 1997; 12(4):205-9. PubMed ID: 9354878
[TBL] [Abstract][Full Text] [Related]
28. Fetal supraventricular tachycardia complicated by hydrops fetalis: a role for direct fetal intramuscular therapy.
Parilla BV; Strasburger JF; Socol ML
Am J Perinatol; 1996 Nov; 13(8):483-6. PubMed ID: 8989479
[TBL] [Abstract][Full Text] [Related]
29. Refractory fetal supraventricular tachycardia and obstetric cholestasis.
Shand AW; Dickinson JE; D'Orsogna L
Fetal Diagn Ther; 2008; 24(3):277-81. PubMed ID: 18765943
[TBL] [Abstract][Full Text] [Related]
30. Long-term neurodevelopmental outcome after fetal arrhythmia.
Lopriore E; Aziz MI; Nagel HT; Blom NA; Rozendaal L; Kanhai HH; Vandenbussche FP
Am J Obstet Gynecol; 2009 Jul; 201(1):46.e1-5. PubMed ID: 19344880
[TBL] [Abstract][Full Text] [Related]
31. [Long-term outcome of children with prenatal diagnosed tachyarrhythmia].
Krapp M; Baumann K; Axt-Fliedner R; Germer U; Gembruch U; Weichert J
Ultraschall Med; 2011 Dec; 32 Suppl 2():E175-81. PubMed ID: 21614748
[TBL] [Abstract][Full Text] [Related]
32. Transplacental Therapeutic Drug Monitoring in Pregnant Women with Fetal Tachyarrhythmia Using HPLC-MS/MS.
Starodubtseva N; Kindysheva S; Potapova A; Kukaev E; Khodzhaeva Z; Bockeria E; Chagovets V; Frankevich V; Sukhikh G
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768172
[TBL] [Abstract][Full Text] [Related]
33. Outcomes of very-low-birthweight infants at 3 years of age born in 2003-2004 in Japan.
Kono Y; Mishina J; Yonemoto N; Kusuda S; Fujimura M
Pediatr Int; 2011 Dec; 53(6):1051-8. PubMed ID: 21917065
[TBL] [Abstract][Full Text] [Related]
34. Neurological morbidity after fetal supraventricular tachyarrhythmia.
Schade RP; Stoutenbeek P; de Vries LS; Meijboom EJ
Ultrasound Obstet Gynecol; 1999 Jan; 13(1):43-7. PubMed ID: 10201085
[TBL] [Abstract][Full Text] [Related]
35. Influence of gestational age on death and neurodevelopmental outcome in premature infants with severe intracranial hemorrhage.
Goldstein RF; Cotten CM; Shankaran S; Gantz MG; Poole WK;
J Perinatol; 2013 Jan; 33(1):25-32. PubMed ID: 22814942
[TBL] [Abstract][Full Text] [Related]
36. Association of Neurodevelopmental Outcomes and Neonatal Morbidities of Extremely Premature Infants With Differential Exposure to Antenatal Steroids.
Chawla S; Natarajan G; Shankaran S; Pappas A; Stoll BJ; Carlo WA; Saha S; Das A; Laptook AR; Higgins RD;
JAMA Pediatr; 2016 Dec; 170(12):1164-1172. PubMed ID: 27723868
[TBL] [Abstract][Full Text] [Related]
37. Long-term neurodevelopmental outcome after intrauterine transfusion for hemolytic disease of the fetus/newborn: the LOTUS study.
Lindenburg IT; Smits-Wintjens VE; van Klink JM; Verduin E; van Kamp IL; Walther FJ; Schonewille H; Doxiadis II; Kanhai HH; van Lith JM; van Zwet EW; Oepkes D; Brand A; Lopriore E;
Am J Obstet Gynecol; 2012 Feb; 206(2):141.e1-8. PubMed ID: 22030316
[TBL] [Abstract][Full Text] [Related]
38. Transplacental digoxin therapy for fetal tachyarrhythmia with multiple evaluation systems.
Zhou K; Hua Y; Zhu Q; Liu H; Yang S; Zhou R; Guo N
J Matern Fetal Neonatal Med; 2011 Nov; 24(11):1378-83. PubMed ID: 21689050
[TBL] [Abstract][Full Text] [Related]
39. Management of Fetal Supraventricular Tachycardia: Case Series from a Tertiary Perinatal Cardiac Center.
Broom E; Thomas JT; Petersen S; Gooi A; Ward C; Gardener G; Kostner K; Lee-Tannock A; Kumar S
Fetal Diagn Ther; 2021; 48(11-12):794-800. PubMed ID: 34753148
[TBL] [Abstract][Full Text] [Related]
40. Flecainide as first-line treatment for fetal supraventricular tachycardia.
Ekiz A; Kaya B; Bornaun H; Acar DK; Avci ME; Bestel A; Yildirim G
J Matern Fetal Neonatal Med; 2018 Feb; 31(4):407-412. PubMed ID: 28114840
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
